Stay updated on Zimura for AMD: Phase 3 Clinical Trial
Sign up to get notified when there's something new on the Zimura for AMD: Phase 3 Clinical Trial page.

Latest updates to the Zimura for AMD: Phase 3 Clinical Trial page
- Check7 days agoChange DetectedThe changes shift the page toward a stricter data-sharing stance by removing specific IPD sharing details and study documents, while adding general dates and a reiteration of the policy link. This reduces accessibility of study data and documents.SummaryDifference5%

- Check14 days agoNo Change Detected
- Check21 days agoChange Detected- Added an important operating-status notice and links (affecting core content and user expectations). - Updated version from v3.1.0 to v3.2.0.SummaryDifference2%

- Check29 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.1%

- Check50 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.1%

- Check57 days agoChange DetectedThe web page has been updated to include new facility names and locations, as well as detailed drug information regarding Avacincaptad Pegol. Additionally, several previous location entries have been removed, indicating a refinement in the information presented.SummaryDifference9%

Stay in the know with updates to Zimura for AMD: Phase 3 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zimura for AMD: Phase 3 Clinical Trial page.